School of Medicine
Showing 121-130 of 143 Results
-
Michael Snyder, Ph.D.
Stanford W. Ascherman Professor of Genetics
On Partial Leave from 12/02/2024 To 12/01/2025Current Research and Scholarly InterestsOur laboratory use different omics approaches to study a) regulatory networks, b) intra- and inter-species variation which differs primarily at the level of regulatory information c) human health and disease. For the later we have established integrated Personal Omics Profiling (iPOP), an analysis that combines longitudinal analyses of genomic, transcriptomic, proteomic, metabolomic, DNA methylation, microbiome and autoantibody profiles to monitor healthy and disease states
-
Justin L. Sonnenburg
Alex and Susie Algard Endowed Professor
Current Research and Scholarly InterestsThe goals of the Sonnenburg Lab research program are to (i) elucidate the basic mechanisms that underlie dynamics within the gut microbiota and (ii) devise and implement strategies to prevent and treat disease in humans via the gut microbiota. We investigate the principles that govern gut microbial community function and interaction with the host using a broad range of experimental approaches including studies of microbiomes in diverse human cohorts.
-
Sarah Streett
Clinical Professor, Medicine - Gastroenterology & Hepatology
BioDr. Sarah Streett is a Clinical Professor of Medicine, the Director of Inflammatory Bowel Disease Education at Stanford, and she is passionate about taking care of people with IBD. She is a national expert in treating complex IBD and initiated a multi-disciplinary approach to care with colorectal surgery, pediatrics, and nutrition. In 2018 she received the Champion of Hope Award from the Crohn’s and Colitis Foundation and serves on their National Scientific Advisory Committee. Her interests focus on fertility and pregnancy in people with IBD, developing precision approaches to IBD therapy, and the role that the microbiome and diet play in its pathogenesis. She is a primary investigator of the Stanford IBD Registry and has research projects focused on optimizing clinical outcomes in IBD, the role of the microbiota and diet in IBD and pregnancy, and applying new technologies to individualizing therapy for IBD. She is also the primary investigator on multiple industry-sponsored IBD trials.
Teaching is a top priority for Dr. Streett who feels that mentoring fellows in the development of their careers is a privilege. She has held many national leadership roles in the American Gastroenterological Association, where she has been Chair of the Practice Management and Economics Committee, and currently serves on the Government Affairs Committee. She also an appointed member of the Gastrointestinal Drug Advisory Committee at the FDA. She has represented the interests of gastroenterologists and their patients on Capitol Hill numerous times. Dr. Streett believes strongly in a collaborative approach to give patients personalized care based on the latest therapies for the treatment of IBD and is committed to mentoring the next generation of experts in the field. -
Ali Bin Syed
Clinical Associate Professor, Radiology - Pediatric Radiology
BioDr. Syed is a member of the divisions of Pediatric Radiology and Body MRI and serves as the Medical Director of Pediatric MRI at Stanford. Dr. Syed has received subspecialty training in adult body imaging, pediatric body imaging, congenital cardiac imaging, and musculoskeletal imaging. His clinical interests include MR imaging of pediatric and adult hepatobiliary disorders, inflammatory bowel disease, gynecologic pathology, and congenital heart disease. He is also an active researcher and works with engineers and scientists to translate technical innovations in MRI into improved patient care. His recent work focuses on translation of machine learning techniques for rapid, robust MRI in children and adults.
-
Christoph Thaiss
Assistant Professor of Pathology
Current Research and Scholarly InterestsThe Thaiss Lab investigates how gut-brain interactions influence health and disease. By studying microbiome-host communication, the lab explores how microbial signals impact immune function, metabolism, and neurological health. Using multi-omic technologies and computational models, they aim to uncover mechanisms underlying inflammation, neurological disorders, and metabolic diseases. Their research supports the development of personalized therapies targeting the gut-brain axis.
-
Ertug Toroslu
Visiting Instructor, Pediatrics - Gastroenterology
BioDr. Toroslu graduated from Ege University School of Medicine in Turkey in 2010. He completed his training in Pediatric Gastroenterology, Hepatology, and Nutrition at Koç University School of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, in 2023.
As a pediatric gastroenterologist, he has a dedicated focus on non-invasive tools for the care and research of pediatric inflammatory bowel disease (IBD). He was certified by the International Bowel Ultrasound Group (IBUS) and actively involved in several leading professional organizations, including IBUS, the European Crohn’s and Colitis Organization (ECCO), the European Society of Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), and the Turkish Society for Pediatric Gastroenterology, Hepatology and Nutrition (TCGHD).
His clinical and research interests center on the advancement of intestinal ultrasound and other non-invasive modalities for the diagnosis, monitoring, and management of pediatric IBD. -
Khang Tran, DO MBA
Fellow in Pediatrics - Gastroenterology
BioKansas City University of Medicine and Biosciences -- Doctor of Osteopathic Medicine and Master of Business Administration (2019)
Good Samaritan University Hospital Medical Center -- Pediatric Residency (2019 - 2022)
UCLA Mattel Children's Hospital -- Pediatric Gastroenterology Fellowship (2022 - 2025)
Dr. Tran is passionate about advancing care for children with complex inflammatory bowel disease. Clinically, he aims to deepen his expertise in immunology, gain hands-on experience with emerging therapies and diagnostics, and develop the leadership skills necessary to coordinate multidisciplinary IBD care
His research focuses on global medicine and health equity, particularly in expanding access to high-quality IBD care worldwide. He also has a strong interest in the discovery and validation of biomarkers and predictive models for treatment response to advanced therapies, with the ultimate goal of personalizing care for children with IBD.
Dr. Tran is very excited to contribute to Stanford’s innovative IBD program and to collaborate with clinicians and scientists who are shaping the future of pediatric IBD care.
